DAVID M MOTT Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID M MOTT.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).

Latest Insider Trading Transactions of DAVID M MOTT

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2021	NVAX	NOVAVAX INC	MOTT DAVID M	Director	Option Exercise	A	0.00	700	0	700
Jun 22 2021	NVAX	NOVAVAX INC	MOTT DAVID M	Director	Option Exercise	A	179.89	1,300	233,857	1,300
Apr 01 2021	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	8.71	2,727	23,752	153,627	150.9 K to 153.6 K (+1.81 %)
Jan 20 2021	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	21.09	4,528	95,496	4,528
Jan 05 2021	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	10.86	2,158	23,436	88,183	86 K to 88.2 K (+2.51 %)
Dec 15 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	486	0	9,595	9.1 K to 9.6 K (+5.34 %)
Dec 15 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	1,096	0	9,109	8 K to 9.1 K (+13.68 %)
Dec 10 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	5.89	170,000	1,000,841	417,284	247.3 K to 417.3 K (+68.75 %)
Nov 12 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	1,112	0	6,400	5.3 K to 6.4 K (+21.03 %)
Nov 12 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	496	0	5,288	4.8 K to 5.3 K (+10.35 %)
Nov 12 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	496	0	4,792	4.3 K to 4.8 K (+11.55 %)
Nov 12 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	1,106	0	4,296	3.2 K to 4.3 K (+34.67 %)
Oct 01 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	11.93	1,965	23,442	86,025	84.1 K to 86 K (+2.34 %)
Sep 28 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	12.66	50,000	633,000	50,000
Jul 01 2020	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	1.67	226,753	378,678	226,753
Jul 01 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	16.06	1,459	23,432	84,060	82.6 K to 84.1 K (+1.77 %)
Jun 29 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	22.90	9,200	210,680	9,200
Jun 26 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	P	16.03	62,019	994,165	82,601	20.6 K to 82.6 K (+301.33 %)
Jun 26 2020	NVAX	NOVAVAX INC	MOTT DAVID M	Director	Option Exercise	A	83.54	4,400	367,576	4,400
Jun 26 2020	NVAX	NOVAVAX INC	MOTT DAVID M	Director	Option Exercise	A	83.54	4,400	367,576	4,400
Jun 26 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	6.96	68,373	476,040	247,284	178.9 K to 247.3 K (+38.22 %)
Jun 26 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	6.75	72,598	489,862	178,911	106.3 K to 178.9 K (+68.29 %)
Jun 24 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	P	6.75	4,673	31,525	106,313	101.6 K to 106.3 K (+4.60 %)
Jun 22 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	J	0.00	67,662	0	106,959	39.3 K to 107 K (+172.18 %)
Jun 18 2020	NVAX	NOVAVAX INC	MOTT DAVID M	Director	Option Exercise	A	52.15	8,000	417,200	8,000
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	7.31	75,000	548,250	75,000
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	7.31	23,500	171,785	23,500
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Buy	J	0.00	1,079	0	101,640	100.6 K to 101.6 K (+1.07 %)
Jun 11 2020	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	12,995	0	100,561	87.6 K to 100.6 K (+14.84 %)
Jun 02 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	17.55	14,013	245,928	14,013
Apr 13 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	993	0	3,190	2.2 K to 3.2 K (+45.20 %)
Apr 13 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	J	0.00	2,197	0	2,197	0 to 2.2 K
Apr 09 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	P	5.59	538,599	3,010,768	538,599	0 to 538.6 K
Apr 02 2020	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	15.51	1,512	23,451	20,582	19.1 K to 20.6 K (+7.93 %)
Mar 16 2020	IMRA	IMARA Inc.	MOTT DAVID M	Director	Option Exercise	A	16.00	15,457	247,312	15,457
Jan 28 2020	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	0.67	7,500,000	5,000,250	19,500,000	12 M to 19.5 M (+62.50 %)
Jan 03 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	5.36	19,713	105,662	19,713
Jan 03 2020	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	5.36	19,713	105,662	19,713
Dec 26 2019	RGLS	Regulus Therapeuti ...	MOTT DAVID M	10% Owner	Option Exercise	P	0.00	900,900	0	900,900
Dec 26 2019	RGLS	Regulus Therapeuti ...	MOTT DAVID M	10% Owner	Option Exercise	P	0.67	9,009,000	5,999,994	9,009,000
Dec 09 2019	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	6.25	400,000	2,500,000	3,482,186	3.1 M to 3.5 M (+12.98 %)
Oct 02 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	10.32	2,271	23,437	18,118	15.8 K to 18.1 K (+14.33 %)
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	29,889,945	0	0
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	MOTT DAVID M	10% Owner	Buy	P	15.00	450,000	6,750,000	4,186,243	3.7 M to 4.2 M (+12.04 %)
Jul 24 2019	MIRM	Mirum Pharmaceutic ...	MOTT DAVID M	10% Owner	Buy	C	0.00	3,736,243	0	3,736,243	0 to 3.7 M
Jul 03 2019	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	0.61	350,947	214,078	350,947
Jun 28 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Sell	S	12.43	52,473	652,134	0	52.5 K to 0 (-100.00 %)
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Sell	S	12.85	52,472	674,176	52,473	104.9 K to 52.5 K (-50.00 %)
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Sell	S	13.31	52,472	698,649	104,945	157.4 K to 104.9 K (-33.33 %)
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	J	0.00	157,417	0	157,417	0 to 157.4 K
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	J	0.00	38,646	0	39,297	651 to 39.3 K (+5,936.41 %)
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Sell	J	0.00	767,500	0	0	767.5 K to 0 (-100.00 %)
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	J	0.00	767,500	0	767,500	0 to 767.5 K
Jun 26 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Sell	J	0.00	2,500,000	0	3,971,018	6.5 M to 4 M (-38.63 %)
Jun 25 2019	GNCA	GENOCEA BIOSCIENCE ...	MOTT DAVID M	10% Owner	Buy	P	3.50	2,857,142	9,999,997	7,225,676	4.4 M to 7.2 M (+65.40 %)
Jun 25 2019	GNCA	GENOCEA BIOSCIENCE ...	MOTT DAVID M	10% Owner	Buy	P	3.50	2,857,142	9,999,997	7,225,676	4.4 M to 7.2 M (+65.40 %)
Jun 17 2019	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	2.74	50,000	137,000	50,000
Jun 17 2019	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	32,846	0	87,566	54.7 K to 87.6 K (+60.03 %)
Jun 11 2019	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	4.31	25,000	107,750	25,000
Jun 07 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	13.74	17,633	242,277	17,633
Jun 07 2019	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	12.39	1,891	23,429	13,979	12.1 K to 14 K (+15.64 %)
Jun 07 2019	NITE	Nightstar Therapeu ...	MOTT DAVID M	Director	Option Exercise	D	13.57	21,000	284,970	0
Jun 07 2019	NITE	Nightstar Therapeu ...	MOTT DAVID M	Director	Option Exercise	D	12.27	36,400	446,628	0
Jun 07 2019	NITE	Nightstar Therapeu ...	MOTT DAVID M	Director	Sell	D	25.50	6,662,532	169,894,566	0	6.7 M to 0 (-100.00 %)
May 13 2019	TRVI	Trevi Therapeutics ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	17,099,315	0	0
May 13 2019	TRVI	Trevi Therapeutics ...	MOTT DAVID M	10% Owner	Buy	P	10.00	1,500,000	15,000,000	4,438,562	2.9 M to 4.4 M (+51.05 %)
May 13 2019	TRVI	Trevi Therapeutics ...	MOTT DAVID M	10% Owner	Buy	P	10.00	1,000,000	10,000,000	2,938,562	1.9 M to 2.9 M (+51.58 %)
May 13 2019	TRVI	Trevi Therapeutics ...	MOTT DAVID M	10% Owner	Buy	C	0.00	1,938,562	0	1,938,562	0 to 1.9 M
May 09 2019	RGLS	Regulus Therapeuti ...	MOTT DAVID M	10% Owner	Option Exercise	P	0.00	256,700	0	256,700
May 09 2019	RGLS	Regulus Therapeuti ...	MOTT DAVID M	10% Owner	Option Exercise	P	1.08	3,703,704	4,000,000	3,703,704
May 09 2019	RGLS	Regulus Therapeuti ...	MOTT DAVID M	10% Owner	Buy	P	1.08	1,136,704	1,227,640	2,052,454	915.8 K to 2.1 M (+124.13 %)
Apr 08 2019	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Option Exercise	P	1.25	4,347,827	5,434,784	4,347,827
Apr 08 2019	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.14	4,347,827	4,956,523	25,243,865	20.9 M to 25.2 M (+20.81 %)
Mar 06 2019	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Buy	P	4.00	3,750,000	15,000,000	11,890,138	8.1 M to 11.9 M (+46.07 %)
Jan 29 2019	NITE	Nightstar Therapeu ...	MOTT DAVID M	Director	Option Exercise	A	13.57	21,000	284,970	21,000
Jan 29 2019	NITE	Nightstar Therapeu ...	MOTT DAVID M	Director	Option Exercise	A	13.57	21,000	284,970	21,000
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	46.89	7,290	341,828	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	149.22	12,000	1,790,640	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	47.27	12,000	567,240	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	60.77	10,000	607,700	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	26.36	10,000	263,600	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	46.22	10,000	462,200	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	D	0.00	4,052	0	0
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Sell	U	75.00	1,333	99,975	0	1.3 K to 0 (-100.00 %)
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Sell	U	75.00	739,517	55,463,775	0	739.5 K to 0 (-100.00 %)
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Sell	U	75.00	9,681,038	726,077,850	0	9.7 M to 0 (-100.00 %)
Jan 22 2019	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Sell	U	75.00	15,362	1,152,150	0	15.4 K to 0 (-100.00 %)
Jan 04 2019	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	4.31	25,292	109,009	25,292
Dec 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.49	300,000	448,380	20,896,038	20.6 M to 20.9 M (+1.46 %)
Dec 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.63	200,000	326,060	20,596,038	20.4 M to 20.6 M (+0.98 %)
Dec 12 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.98	61,200	121,084	20,396,038	20.3 M to 20.4 M (+0.30 %)
Dec 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.98	26,000	51,576	20,334,838	20.3 M to 20.3 M (+0.13 %)
Dec 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.98	117,100	232,362	20,308,838	20.2 M to 20.3 M (+0.58 %)
Dec 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.99	27,300	54,414	20,191,738	20.2 M to 20.2 M (+0.14 %)
Nov 30 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.98	71,900	142,067	20,164,438	20.1 M to 20.2 M (+0.36 %)
Nov 30 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.99	24,500	48,824	20,092,538	20.1 M to 20.1 M (+0.12 %)
Nov 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.98	170,000	336,107	20,068,038	19.9 M to 20.1 M (+0.85 %)
Nov 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.98	170,000	336,107	20,068,038	19.9 M to 20.1 M (+0.85 %)
Nov 19 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.88	510,000	956,658	19,898,038	19.4 M to 19.9 M (+2.63 %)
Nov 19 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.86	350,000	649,355	19,388,038	19 M to 19.4 M (+1.84 %)
Nov 19 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.86	340,000	631,958	19,038,038	18.7 M to 19 M (+1.82 %)
Oct 10 2018	ESTC	Elastic N.V.	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	1,528,117	0	0
Oct 10 2018	ESTC	Elastic N.V.	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	4,155,995	0	0
Oct 10 2018	ESTC	Elastic N.V.	MOTT DAVID M	10% Owner	Buy	C	0.00	1,528,117	0	1,528,117	0 to 1.5 M
Oct 10 2018	ESTC	Elastic N.V.	MOTT DAVID M	10% Owner	Buy	C	0.00	4,155,995	0	4,155,995	0 to 4.2 M
Oct 05 2018	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Buy	P	9.00	416,667	3,750,003	6,471,018	6.1 M to 6.5 M (+6.88 %)
Sep 21 2018	MRSN	Mersana Therapeuti ...	MOTT DAVID M	Director	Option Exercise	A	12.27	10,000	122,700	10,000
Sep 10 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.67	12,000,000	20,000,400	12,000,000	0 to 12 M
Sep 10 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.67	3,000,000	5,000,100	82,978,668	80 M to 83 M (+3.75 %)
Aug 22 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.26	663,716	1,499,998	18,698,038	18 M to 18.7 M (+3.68 %)
Jul 20 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.00	50,600	101,165	18,034,322	18 M to 18 M (+0.28 %)
Jul 20 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	1.95	200,000	390,580	17,983,722	17.8 M to 18 M (+1.12 %)
Jul 02 2018	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Grant	A	13.55	6,088	82,492	12,088	6 K to 12.1 K (+101.47 %)
Jun 28 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.10	187,130	392,692	17,783,722	17.6 M to 17.8 M (+1.06 %)
Jun 28 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.15	5,295	11,384	17,596,592	17.6 M to 17.6 M (+0.03 %)
Jun 26 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	2.18	187,330	408,379	187,330
Jun 15 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Option Exercise	A	4.03	15,000	60,450	15,000
Jun 15 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	0.00	20,843	0	54,720	33.9 K to 54.7 K (+61.53 %)
Jun 05 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	A	0.00	4,052	0	4,052
Jun 05 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Option Exercise	A	46.89	7,209	338,030	7,209
Jun 05 2018	TSRO	TESARO, Inc.	MOTT DAVID M	Director	Grant	A	0.00	2,537	0	15,362	12.8 K to 15.4 K (+19.78 %)
May 31 2018	EPZM	Epizyme, Inc.	MOTT DAVID M	Director	Option Exercise	A	17.00	12,500	212,500	12,500
May 30 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.15	275	591	17,591,297	17.6 M to 17.6 M (0.00 %)
May 30 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	4.00	416,667	1,666,668	3,082,186	2.7 M to 3.1 M (+15.63 %)
May 30 2018	ARDX	ARDELYX, INC.	MOTT DAVID M	Director	Grant	A	4.00	416,666	1,666,664	3,082,186	2.7 M to 3.1 M (+15.63 %)
May 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.14	32,200	69,059	17,591,022	17.6 M to 17.6 M (+0.18 %)
May 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.14	20,100	42,928	17,558,822	17.5 M to 17.6 M (+0.11 %)
May 21 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.13	184,179	391,436	17,538,722	17.4 M to 17.5 M (+1.06 %)
May 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.13	70,873	151,250	17,354,543	17.3 M to 17.4 M (+0.41 %)
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	858,978	0	0
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	2,576,939	0	0
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	12,679,970	0	0
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Sell	U	0.00	858,978	0	0	859 K to 0 (-100.00 %)
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Buy	C	0.00	858,978	0	858,978	0 to 859 K
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Sell	U	0.00	2,576,939	0	0	2.6 M to 0 (-100.00 %)
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Buy	C	0.00	2,576,939	0	2,576,939	0 to 2.6 M
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Sell	U	0.00	12,679,970	0	0	12.7 M to 0 (-100.00 %)
May 09 2018	MULE	MULESOFT, INC	MOTT DAVID M	10% Owner	Buy	C	0.00	12,679,970	0	12,679,970	0 to 12.7 M
Apr 23 2018	SURF	Surface Oncology, ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	6,995,000	0	0
Apr 23 2018	SURF	Surface Oncology, ...	MOTT DAVID M	10% Owner	Buy	P	15.00	133,333	1,999,995	3,312,877	3.2 M to 3.3 M (+4.19 %)
Apr 23 2018	SURF	Surface Oncology, ...	MOTT DAVID M	10% Owner	Buy	C	0.00	3,179,544	0	3,179,544	0 to 3.2 M
Apr 23 2018	SURF	Surface Oncology, ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	6,995,000	0	0
Apr 23 2018	SURF	Surface Oncology, ...	MOTT DAVID M	10% Owner	Buy	P	15.00	133,333	1,999,995	3,312,877	3.2 M to 3.3 M (+4.19 %)
Apr 23 2018	SURF	Surface Oncology, ...	MOTT DAVID M	10% Owner	Buy	C	0.00	3,179,544	0	3,179,544	0 to 3.2 M
Apr 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.46	203,200	499,994	17,283,670	17.1 M to 17.3 M (+1.19 %)
Apr 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.43	32,100	78,099	17,080,470	17 M to 17.1 M (+0.19 %)
Apr 10 2018	AVEO	AVEO PHARMACEUTICA ...	MOTT DAVID M	10% Owner	Buy	P	2.24	685,676	1,536,943	17,048,370	16.4 M to 17 M (+4.19 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 27 2018	TCON	Tracon Pharmaceuti ...	MOTT DAVID M	10% Owner	Option Exercise	P	2.70	707,964	1,911,503	707,964

Page: 1 2 next >